These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 11095320

  • 1. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE, Bochenek W.
    Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
    [Abstract] [Full Text] [Related]

  • 2. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
    Wo JM, Koopman J, Harrell SP, Parker K, Winstead W, Lentsch E.
    Am J Gastroenterol; 2006 Sep; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J, van Rensburg C, Vieweg W, Fischer R.
    Digestion; 2004 Sep; 70(1):61-9. PubMed ID: 15297779
    [Abstract] [Full Text] [Related]

  • 5. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
    Bochenek WJ, Mack ME, Fraga PD, Metz DC.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1105-14. PubMed ID: 15569113
    [Abstract] [Full Text] [Related]

  • 6. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL, Houcke P, Samoyeau R, French Collaborative Pantaprazole Study Group.
    Gastroenterol Clin Biol; 2001 Mar 15; 25(3):245-50. PubMed ID: 11395670
    [Abstract] [Full Text] [Related]

  • 7. Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial.
    Pratha V, Hogan DL, Lynn RB, Field B, Metz DC.
    Dig Dis Sci; 2006 Sep 15; 51(9):1595-601. PubMed ID: 16927137
    [Abstract] [Full Text] [Related]

  • 8. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE, Fraga P, Mack M, Sabesin SM, Bochenek W, Pantoprazole US GERD Study Group.
    Aliment Pharmacol Ther; 2004 Sep 01; 20(5):567-75. PubMed ID: 15339328
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.
    Wurzer H, Schutze K, Bethke T, Fischer R, Luhmann R, Riesenhuber C.
    Hepatogastroenterology; 1999 Sep 01; 46(27):1809-15. PubMed ID: 10430350
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM.
    Am J Gastroenterol; 1996 Sep 01; 91(9):1749-57. PubMed ID: 8792693
    [Abstract] [Full Text] [Related]

  • 11. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T, Schütze K, van Leendert RJ, Fumagalli I, Costa Neves B, Bohuschke M, Gatz G.
    Digestion; 2003 Sep 01; 67(1-2):6-13. PubMed ID: 12743434
    [Abstract] [Full Text] [Related]

  • 12. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL, Dorsch E, Jones J, Jennings DE, Greski-Rose PA.
    Am J Gastroenterol; 1998 Feb 01; 93(2):238-43. PubMed ID: 9468251
    [Abstract] [Full Text] [Related]

  • 13. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
    Labenz J, Armstrong D, Lauritsen K, Katelaris P, Schmidt S, Schütze K, Wallner G, Juergens H, Preiksaitis H, Keeling N, Nauclér E, Adler J, Eklund S.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):803-11. PubMed ID: 16225489
    [Abstract] [Full Text] [Related]

  • 14. On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial.
    Scholten T, Dekkers CP, Schütze K, Körner T, Bohuschke M, Gatz G.
    Digestion; 2005 Nov 01; 72(2-3):76-85. PubMed ID: 16113546
    [Abstract] [Full Text] [Related]

  • 15. Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States.
    Caos A, Breiter J, Perdomo C, Barth J.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):193-202. PubMed ID: 16091056
    [Abstract] [Full Text] [Related]

  • 16. Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group.
    Caos A, Moskovitz M, Dayal Y, Perdomo C, Niecestro R, Barth J.
    Am J Gastroenterol; 2000 Nov 01; 95(11):3081-8. PubMed ID: 11095321
    [Abstract] [Full Text] [Related]

  • 17. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S, Dibildox M, Moguel A, Di Silvio M, Rodríguez F, Almaguer I, García C.
    Rev Gastroenterol Mex; 1998 Nov 01; 63(1):11-6. PubMed ID: 10068743
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO, Wilcox CM, DeVault K, Miska D, Bochenek W, Pantoprozole US Gerd Study Group B.
    Aliment Pharmacol Ther; 2002 Dec 01; 16(12):2043-52. PubMed ID: 12452936
    [Abstract] [Full Text] [Related]

  • 19. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A, Stimac D, Vceva A, Takac B, Ivandić A, Pezerović D, Horvat D, Nedić P, Kotromanović Z, Maksimović Z, Vranjes Z, Males J, Jurisić-Orzen D, Vladika I, Stimac T, Mandić B.
    Acta Med Croatica; 1999 Dec 01; 53(2):79-82. PubMed ID: 10705625
    [Abstract] [Full Text] [Related]

  • 20. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
    Dettmer A, Vogt R, Sielaff F, Lühmann R, Schneider A, Fischer R.
    Aliment Pharmacol Ther; 1998 Sep 01; 12(9):865-72. PubMed ID: 9768529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.